nodes	percent_of_prediction	percent_of_DWPC	metapath
Nadolol—Penbutolol—HTR1B—attention deficit hyperactivity disorder	0.0138	0.581	CrCbGaD
Nadolol—Pindolol—HTR1B—attention deficit hyperactivity disorder	0.00993	0.419	CrCbGaD
Nadolol—ADRB2—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.00658	0.00674	CbGpPWpGaD
Nadolol—ADRB2—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.0065	0.00666	CbGpPWpGaD
Nadolol—ADRB1—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.00639	0.00655	CbGpPWpGaD
Nadolol—ADRB2—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.00625	0.0064	CbGpPWpGaD
Nadolol—ADRB1—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.00619	0.00634	CbGpPWpGaD
Nadolol—ADRB3—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.00614	0.00629	CbGpPWpGaD
Nadolol—ADRB2—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.00606	0.0062	CbGpPWpGaD
Nadolol—ADRB1—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.00594	0.00609	CbGpPWpGaD
Nadolol—ADRB1—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.0059	0.00604	CbGpPWpGaD
Nadolol—ADRB2—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.00581	0.00595	CbGpPWpGaD
Nadolol—ADRB1—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.00575	0.00589	CbGpPWpGaD
Nadolol—ADRB1—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.00566	0.00579	CbGpPWpGaD
Nadolol—ADRB2—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.00563	0.00577	CbGpPWpGaD
Nadolol—ADRB1—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.00559	0.00572	CbGpPWpGaD
Nadolol—ADRB2—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.00553	0.00567	CbGpPWpGaD
Nadolol—ADRB2—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.00546	0.0056	CbGpPWpGaD
Nadolol—ADRB1—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.0052	0.00533	CbGpPWpGaD
Nadolol—ADRB2—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.00509	0.00521	CbGpPWpGaD
Nadolol—ADRB1—G alpha (s) signalling events—DRD5—attention deficit hyperactivity disorder	0.00435	0.00446	CbGpPWpGaD
Nadolol—ADRB1—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.00434	0.00444	CbGpPWpGaD
Nadolol—ADRB2—G alpha (s) signalling events—DRD5—attention deficit hyperactivity disorder	0.00426	0.00436	CbGpPWpGaD
Nadolol—ADRB2—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.00424	0.00434	CbGpPWpGaD
Nadolol—ADRB3—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00416	0.00427	CbGpPWpGaD
Nadolol—ADRB3—G alpha (s) signalling events—DRD1—attention deficit hyperactivity disorder	0.00413	0.00423	CbGpPWpGaD
Nadolol—ADRB3—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00408	0.00418	CbGpPWpGaD
Nadolol—ADRB3—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.00408	0.00418	CbGpPWpGaD
Nadolol—ADRB3—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00405	0.00415	CbGpPWpGaD
Nadolol—ADRB1—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.00364	0.00373	CbGpPWpGaD
Nadolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00357	0.00366	CbGpPWpGaD
Nadolol—ADRB2—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.00357	0.00365	CbGpPWpGaD
Nadolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.0035	0.00358	CbGpPWpGaD
Nadolol—ADRB2—GPCRs, Other—DRD3—attention deficit hyperactivity disorder	0.00297	0.00305	CbGpPWpGaD
Nadolol—ADRB2—GPCRs, Other—DRD4—attention deficit hyperactivity disorder	0.00289	0.00296	CbGpPWpGaD
Nadolol—ADRB3—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00283	0.0029	CbGpPWpGaD
Nadolol—ADRB3—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00272	0.00278	CbGpPWpGaD
Nadolol—ADRB3—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00266	0.00273	CbGpPWpGaD
Nadolol—ADRB3—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00247	0.00253	CbGpPWpGaD
Nadolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00247	0.00253	CbGpPWpGaD
Nadolol—ADRB1—G alpha (s) signalling events—DRD1—attention deficit hyperactivity disorder	0.00245	0.00251	CbGpPWpGaD
Nadolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00242	0.00248	CbGpPWpGaD
Nadolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00242	0.00248	CbGpPWpGaD
Nadolol—ADRB1—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.00242	0.00248	CbGpPWpGaD
Nadolol—ADRB2—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00242	0.00248	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.0024	0.00246	CbGpPWpGaD
Nadolol—ADRB2—G alpha (s) signalling events—DRD1—attention deficit hyperactivity disorder	0.0024	0.00246	CbGpPWpGaD
Nadolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00237	0.00243	CbGpPWpGaD
Nadolol—ADRB2—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.00237	0.00243	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00235	0.00241	CbGpPWpGaD
Nadolol—ADRB3—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.0023	0.00235	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00229	0.00235	CbGpPWpGaD
Nadolol—ADRB3—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00223	0.00228	CbGpPWpGaD
Nadolol—ADRB3—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00219	0.00224	CbGpPWpGaD
Nadolol—ADRB3—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00216	0.00221	CbGpPWpGaD
Nadolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00212	0.00217	CbGpPWpGaD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00212	0.00217	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00208	0.00213	CbGpPWpGaD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00207	0.00213	CbGpPWpGaD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00207	0.00212	CbGpPWpGaD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00203	0.00208	CbGpPWpGaD
Nadolol—ADRB3—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00201	0.00206	CbGpPWpGaD
Nadolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00197	0.00202	CbGpPWpGaD
Nadolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00191	0.00195	CbGpPWpGaD
Nadolol—ADRB2—GPCRs, Other—HTR2A—attention deficit hyperactivity disorder	0.00188	0.00193	CbGpPWpGaD
Nadolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00187	0.00192	CbGpPWpGaD
Nadolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00185	0.0019	CbGpPWpGaD
Nadolol—ADRB3—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00185	0.00189	CbGpPWpGaD
Nadolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00172	0.00177	CbGpPWpGaD
Nadolol—ADRB1—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00168	0.00172	CbGpPWpGaD
Nadolol—ADRB2—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00164	0.00168	CbGpPWpGaD
Nadolol—ADRB3—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00161	0.00165	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00161	0.00165	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00158	0.00162	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00158	0.00162	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00155	0.00158	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00154	0.00157	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.0015	0.00154	CbGpPWpGaD
Nadolol—ADRB3—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.0015	0.00154	CbGpPWpGaD
Nadolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00147	0.0015	CbGpPWpGaD
Nadolol—ADRB3—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00145	0.00149	CbGpPWpGaD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00144	0.00147	CbGpPWpGaD
Nadolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00144	0.00147	CbGpPWpGaD
Nadolol—ADRB3—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00143	0.00146	CbGpPWpGaD
Nadolol—ADRB3—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00141	0.00144	CbGpPWpGaD
Nadolol—ADRB3—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00141	0.00144	CbGpPWpGaD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00141	0.00144	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00139	0.00143	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00137	0.0014	CbGpPWpGaD
Nadolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00136	0.0014	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00136	0.00139	CbGpPWpGaD
Nadolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00133	0.00137	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00133	0.00136	CbGpPWpGaD
Nadolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00132	0.00135	CbGpPWpGaD
Nadolol—ADRB3—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00131	0.00135	CbGpPWpGaD
Nadolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.0013	0.00133	CbGpPWpGaD
Nadolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00129	0.00132	CbGpPWpGaD
Nadolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00128	0.00131	CbGpPWpGaD
Nadolol—ADRB2—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00127	0.0013	CbGpPWpGaD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00126	0.00129	CbGpPWpGaD
Nadolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00125	0.00129	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00123	0.00126	CbGpPWpGaD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00123	0.00126	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00123	0.00126	CbGpPWpGaD
Nadolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00121	0.00124	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00121	0.00124	CbGpPWpGaD
Nadolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00119	0.00122	CbGpPWpGaD
Nadolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00117	0.0012	CbGpPWpGaD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00117	0.0012	CbGpPWpGaD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00114	0.00117	CbGpPWpGaD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00113	0.00116	CbGpPWpGaD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00111	0.00114	CbGpPWpGaD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00111	0.00113	CbGpPWpGaD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.0011	0.00113	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.0011	0.00112	CbGpPWpGaD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00109	0.00111	CbGpPWpGaD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00107	0.0011	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00107	0.0011	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00104	0.00107	CbGpPWpGaD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00102	0.00105	CbGpPWpGaD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.001	0.00103	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000959	0.000982	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000957	0.000981	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000947	0.00097	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000936	0.000959	CbGpPWpGaD
Nadolol—ADRB3—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00092	0.000942	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000917	0.00094	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000911	0.000934	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000911	0.000934	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000893	0.000915	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000892	0.000913	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00089	0.000912	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000875	0.000896	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000873	0.000895	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000871	0.000892	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000862	0.000883	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000847	0.000868	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000847	0.000868	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000843	0.000864	CbGpPWpGaD
Nadolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000837	0.000857	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000837	0.000857	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000829	0.000849	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000828	0.000848	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000828	0.000848	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000824	0.000844	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000821	0.000841	CbGpPWpGaD
Nadolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000819	0.000838	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000819	0.000838	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000811	0.000831	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00081	0.000829	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000807	0.000827	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000807	0.000826	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000797	0.000816	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000793	0.000812	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000791	0.000811	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00078	0.000798	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00077	0.000788	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000763	0.000781	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000745	0.000763	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000742	0.00076	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000733	0.00075	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000729	0.000747	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000723	0.000741	CbGpPWpGaD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000717	0.000734	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000713	0.00073	CbGpPWpGaD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000701	0.000718	CbGpPWpGaD
Nadolol—ABCB1—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.000686	0.000703	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000674	0.00069	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.000655	0.000671	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000619	0.000634	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000605	0.00062	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000569	0.000583	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000562	0.000576	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000559	0.000573	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000557	0.00057	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00055	0.000563	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000546	0.000559	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000541	0.000554	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000534	0.000547	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000529	0.000542	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.00052	0.000532	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000503	0.000515	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000492	0.000504	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000491	0.000503	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000489	0.000501	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000489	0.000501	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000487	0.000499	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000481	0.000492	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000479	0.000491	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000479	0.00049	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000478	0.00049	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000476	0.000488	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000473	0.000484	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000472	0.000484	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00047	0.000481	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000469	0.00048	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000468	0.00048	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000463	0.000474	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00046	0.000471	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000457	0.000468	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000455	0.000466	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000447	0.000458	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000442	0.000453	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000441	0.000451	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.00044	0.000451	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000435	0.000445	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000433	0.000443	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000433	0.000443	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000431	0.000441	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000429	0.00044	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000427	0.000438	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000425	0.000436	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00042	0.00043	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.0004	0.00041	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000398	0.000408	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000391	0.000401	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000332	0.00034	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000325	0.000333	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000319	0.000327	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000309	0.000316	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000304	0.000311	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000302	0.000309	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000293	0.0003	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.00029	0.000297	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000284	0.000291	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00028	0.000287	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000279	0.000286	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000274	0.000281	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.00027	0.000276	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000264	0.00027	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000261	0.000268	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000257	0.000263	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000256	0.000262	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000254	0.00026	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000251	0.000257	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000248	0.000254	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000236	0.000242	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000231	0.000237	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00021	0.000215	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00021	0.000215	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000206	0.000211	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000192	0.000197	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000168	0.000172	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000166	0.00017	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000162	0.000166	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00016	0.000164	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000148	0.000151	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000127	0.00013	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000126	0.000129	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	8.77e-05	8.98e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	8.58e-05	8.79e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	5.45e-05	5.58e-05	CbGpPWpGaD
